Japan Clinical Oncology Group (JCOG).
The Japan Clinical Oncology Group (JCOG) is a cooperative oncology group with the aims of conducting, developing, coordinating and stimulating clinical research in Japan on the treatment of cancer and related problems. The purpose of JCOG is to establish and improve the standard of cancer treatment, mainly in solid cancer, through the testing of new therapeutic regimens or combined modalities, using drugs that are newly-approved or already commercially available. Research sponsored by JCOG is accomplished mainly through the execution of large, prospective, randomized, multicenter, clinical trials. In this way, JCOG facilitates the passage of new clinical trial discoveries into state-of-the-art treatment.
Shimoyama
M
M
Department of Internal Medicine, Nagoya National Hospital, Japan. mshimoya@nagoya.hosp.go.jp
Fukuda
H
H
Saijo
N
N
Yamaguchi
N
N
D002986:Clinical Trials as Topic / Q000592:standards*; D006801:Humans; D007564:Japan; D008495:Medical Oncology / Q000458:organization & administration* / Q000639:trends*; D010606:Pharmacy and Therapeutics Committee / Q000458:organization & administration; D012106:Research